This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Manitoba directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $2,757,826
Multicenter RCT to Treat ACute T cell mediated rejection in Kidney and kidney pancreas transpLant rEcIpienTs (TACKLE-IT)
CIHR · 2025 · Co-investigator
- $237,151
Multi-center validation of non-invasive biomarkers of renal allograft outcomes
CIHR · 2019 · Co-investigator
- $2,664,284
A randomized controlled effectiveness trial of urine CXCL10 chemokine monitoring post-renal transplant
CIHR · 2016 · Principal investigator
Multicenter RCT to Treat ACute T cell mediated rejection in Kidney and kidney pancreas transpLant rEcIpienTs (TACKLE-IT)
Principal investigators: Ho, Julie; Nickerson, Peter W; Snelling, Tom; Wiebe, Chris J; Wong, Germaine
Keywords: Adult And Pediatric; Biobank For Future Research; Economic Evaluation; Glucocorticoids, Adverse Effects; Kidney Transplant; Multicenter, International; Noninferiority Randomized Controlled Trial; Patient And Caregiver Engagement; Process Evaluation; T Cell Mediated Rejection
Multi-center validation of non-invasive biomarkers of renal allograft outcomes
Principal investigators: Ho, Julie
Keywords: Ccl2; Chemokine; Cxcl10; Graft Loss; Kidney Transplant Outcome; Multi-Center Prospective Observational Cohort; Prognostic Marker; Transplant Histology; Urine Biomarker; Validation Study
A randomized controlled effectiveness trial of urine CXCL10 chemokine monitoring post-renal transplant
Principal investigators: Ho, Julie; Gibson, Ian W; Hirt-Minkowski, Patricia; Nickerson, Peter W; Rush, David N; Sharma, Atul K; Wiebe, Chris J
Keywords: Ccl2; Chemokines; Cxcl10; Cxcl9; Graft Failure; Randomized Controlled Effectiveness Trial; Rejection; Renal Transplant; Urine Diagnostic Biomarker; Urine Prognostic Biomarker
Chronic Antibody Mediated Rejection: Identification of mechanisms and diagnostic proteins
Principal investigators: Nickerson, Peter W
Keywords: Antibody Mediated Rejection; Biomarkers; Chemokines; Proteomics; Transplantation
Identification of novel proteins as diagnostic or mechanistic targets for renal allograft inflammation.
Principal investigators: Ho, Julie; Gibson, Ian W; Nickerson, Peter W; Rigatto, Claudio; Rush, David N; Wilkins, John A
Keywords: Activity-Based Protein Profiling; Acute Kidney Injury; Catabolomics; Interstitial Fibrosis/Tubular Atrophy & Inflammation; Ischemia Reperfusion Injury; Proteomics; Renal Transplantation; Selected Reaction Monitoring Mass Spectrometry; Subclinical And Clinical Rejection; Urine Biomarker
Non-invasive monitoring of pediatric kidney allograft injury to improve diagnosis and patient outcome.
Principal investigators: Blydt-Hansen, Tom
Keywords: Biomarker; Chemokines; Kidney; Metabolomics; Pediatric; Proteomics; Rejection; Transplantation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.